| Authors: |
Kayani M; UCL Cancer Institute, University College London, London, UK; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Department of Oncology, University College London Hospitals, London, UK., Murphy L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Dutey-Magni P; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Howlett S; UCL Cancer Institute, University College London, London, UK; Department of Oncology, University College London Hospitals, London, UK., Sachdeva A; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Surgery, Christie NHS Foundation Trust, Manchester, UK., Padden-Modi M; Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK., Abdel-Aty H; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK., Brown LC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Amos CL; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Chan K; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Gilbert DC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Langley RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Brown M; Division of Cancer Sciences, University of Manchester, Manchester, UK., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Parker CC; Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK., Cross W; St James's University Hospital, Leeds, UK., Malik Z; Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK., Varughese M; Royal Devon University Healthcare NHS Foundation Trust and University of Exeter, UK., Turco F; Institute of Oncology of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland and Faculty of Biosciences, University of Southern Switzerland, Lugano, Switzerland., Millman R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Matheson D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Gillessen S; Institute of Oncology of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland and Faculty of Biosciences, University of Southern Switzerland, Lugano, Switzerland., Clarke NW; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Surgery, Christie NHS Foundation Trust, Manchester, UK; Department of Urology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., James ND; Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK., Attard G; UCL Cancer Institute, University College London, London, UK; Department of Oncology, University College London Hospitals, London, UK. Electronic address: g.attard@ucl.ac.uk. |
